The elevation of serum myeloperoxidase (MPO) from activated myeloid cells is associated with increased cardiovascular risk through lipid oxidation, induction of endothelial dysfunction, and release of IL-12 from macrophages [27]. Here, MPO is linked to endothelial dysfunction.